A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 14, 2023

Primary Completion Date

March 20, 2025

Study Completion Date

August 28, 2025

Conditions
Metastatic Breast CancerLocally Advanced Breast CancerBreast Cancer
Interventions
DRUG

Samuraciclib

Samuraciclib tablet by mouth once a day

DRUG

Fulvestrant

Injection administered monthly (i.e., every 4 weeks), plus additional dose at Cycle 1 Day 15

Trial Locations (32)

1082

Semmelweis Egyetem, Budapest

2800

Szent Borbala Korhaz, Tatabánya

3100

Nograd Varmegyei Szent Lazar Korhaz, Salgótarján

19107

Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia

21237

Mfsmc-Hjwci, Baltimore

22030

Trakya University, Edirne

28015

MD Anderson Cancer Center, Madrid

28040

Hospital Clinico San Carlos, Madrid

29016

Hospital Vithas Málaga, Málaga

34093

Istanbul Universitesi Istanbul Tıp Fakultesi Hastanesi, Istanbul

34474

Ocala Oncology Center PL DBA Florida Cancer Affiliates, Ocala

34722

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi, Istanbul

35575

I.E.U. Medical Point Hastanesi, Izmir

37007

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca

39002

Hospital Universitario Marqués de Valdecilla, Santander

44280

Actualidad Basada en la Investigación del Cáncer, Guadalajara

44680

Renati Innovation S.A.P.I de C.V, Guadalajara

46010

Hospital Clinico de Valencia, Valencia

64111

Saint Luke's Cancer Institute, Kansas City

68000

Oaxaca Site Management Organization S.C., Oaxaca City

68020

Centro de Investigacion Clinica de Oaxaca, Oaxaca City

76104

The Center for Cancer and Blood Disorders, Fort Worth

03650

Soltmed SMO, Mexico City

06100

Cryptex Investigación Clínica S.A. de C.V., Cuauhtémoc

08908

Institut Català d'Oncologia - L'Hospitalet, L'Hospitalet de Llobregat

06080

Hospital Infanta Cristina, Badajoz

08003

Parc de Salut Mar - Hospital del Mar, Barcelona

08035

Hospital Universitari Vall d'Hebron, Barcelona

06010

Gulhane Egitim ve Arastirma Hastanesi, Ankara

06120

Gazi University, Ankara

06200

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi, Ankara

06230

Hacettepe Universite Hastaneleri, Ankara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Carrick Therapeutics Limited

INDUSTRY